Nektar Therapeutics (NKTR)
1.38
-0.04
(-2.82%)
USD |
NASDAQ |
Apr 24, 16:00
1.39
+0.01
(+0.72%)
After-Hours: 20:00
Nektar Therapeutics Free Cash Flow (Quarterly): -47.28M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -47.28M |
| September 30, 2023 | -42.15M |
| June 30, 2023 | -51.68M |
| March 31, 2023 | -52.35M |
| December 31, 2022 | -58.22M |
| September 30, 2022 | -83.07M |
| June 30, 2022 | -75.77M |
| March 31, 2022 | -92.63M |
| December 31, 2021 | -157.43M |
| September 30, 2021 | -104.07M |
| June 30, 2021 | -86.18M |
| March 31, 2021 | -79.96M |
| December 31, 2020 | -100.39M |
| September 30, 2020 | -54.58M |
| June 30, 2020 | -86.60M |
| March 31, 2020 | -78.98M |
| December 31, 2019 | -128.89M |
| September 30, 2019 | -73.96M |
| June 30, 2019 | -65.56M |
| March 31, 2019 | -86.54M |
| December 31, 2018 | -126.24M |
| September 30, 2018 | -73.23M |
| June 30, 2018 | 956.90M |
| March 31, 2018 | -53.45M |
| December 31, 2017 | -82.79M |
| Date | Value |
|---|---|
| September 30, 2017 | 92.14M |
| June 30, 2017 | -60.78M |
| March 31, 2017 | -38.66M |
| December 31, 2016 | -55.06M |
| September 30, 2016 | -27.87M |
| June 30, 2016 | -15.16M |
| March 31, 2016 | -25.33M |
| December 31, 2015 | -77.58M |
| September 30, 2015 | -18.17M |
| June 30, 2015 | -50.78M |
| March 31, 2015 | 62.25M |
| December 31, 2014 | -28.51M |
| September 30, 2014 | -46.90M |
| June 30, 2014 | -9.753M |
| March 31, 2014 | -66.81M |
| December 31, 2013 | 50.92M |
| September 30, 2013 | -20.30M |
| June 30, 2013 | -34.82M |
| March 31, 2013 | -38.43M |
| December 31, 2012 | -52.22M |
| September 30, 2012 | -29.74M |
| June 30, 2012 | -22.25M |
| March 31, 2012 | -36.13M |
| December 31, 2011 | -43.64M |
| September 30, 2011 | -23.32M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-157.43M
Minimum
Dec 2021
-42.15M
Maximum
Sep 2023
-79.99M
Average
-78.98M
Median
Mar 2020
Free Cash Flow (Quarterly) Benchmarks
| Stereotaxis Inc | -2.439M |
| Vanda Pharmaceuticals Inc | -3.985M |
| Cara Therapeutics Inc | -19.42M |
| Marinus Pharmaceuticals Inc | -27.03M |
| DiaMedica Therapeutics Inc | -3.815M |